HOVANA
生物技术研究
Cambridge，MA 205 位关注者
HOVANA is advancing a pipeline of precision medicines for patients suffering from immunology and neuroscience disorders.
关于我们
Visionaries dream. Innovators create. We are both. HOVANA is a digital biology company powering new possibilities in human health by tackling cellular dysfunction as a driver of serious diseases. Leveraging unprecedented insights into cellular reprogramming, HOVANA is inventing a new class of precision medicines for patients suffering from immunology and neuroscience disorders.
- 网站
-
www.hovana.com
HOVANA的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Cambridge，MA
- 类型
- 私人持股
- 创立
- 2023
- 领域
- drug discovery、precision medicine、immunology、neuroscience、clinical research和digital biology
地点
-
主要
获取路线
US，MA，Cambridge，02139
HOVANA员工
-
Peter Dedon
MIT Professor | tRNA | Epitranscriptome | Epigenome | Codomax Co-founder
-
Nick Davis
Industrializing intelligence | Future-proofing bioinnovation | Building infrastructure for human health, adaptability and resilience
-
Yok Hian Chionh
RNA Biology | Analytical Chemistry | Biotech | Drug Discovery & Development | CMC | Regulatory Science